Inactive Instrument
Acura Pharmaceuticals, Inc. Stock OTC Bulletin Board
Stocks
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-24 | Acura Pharmaceuticals, Inc. Receives $200,000 Loan From Abuse Deterrent Pharma, LLC | CI |
| 06-23 | Acura Pharmaceuticals, Inc. announced that it has received $0.2 million in funding | CI |
| Market Cap | 3.28M 2.85M 2.65M 2.44M 4.6M 313M 4.67M 31.27M 12.27M 156M 12.31M 12.04M 522M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 2.97M 2.76M 2.54M 4.79M 326M 4.86M 32.56M 12.78M 162M 12.82M 12.54M 544M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 2011-03-31 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 2024-07-31 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Wesson
BRD | Director/Board Member | 83 | 1998-02-28 |
William Skelly
CHM | Chairman | 75 | 1996-09-30 |
| Director/Board Member | 55 | 2002-11-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.13% | -3.79% | +34.48% | +157.35% | 25.98B | |
| Weighted average by Cap. | +0.23% | -2.96% | +28.67% | +119.98% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.1M 2.89M 2.65M 5.01M 341M 5.09M 34.05M 13.36M 170M 13.41M 13.11M 569M | 1.56M 1.36M 1.26M 1.16M 2.19M 149M 2.23M 14.91M 5.85M 74.28M 5.87M 5.74M 249M |
| Net income | -1.21M -1.05M -977K -897K -1.69M -115M -1.72M -11.52M -4.52M -57.41M -4.54M -4.44M -193M | -879K -764K -711K -653K -1.23M -83.91M -1.25M -8.38M -3.29M -41.77M -3.3M -3.23M -140M |
| Net Debt | 5.86M 5.09M 4.74M 4.35M 8.22M 559M 8.34M 55.85M 21.92M 278M 21.99M 21.51M 933M | 135K 117K 109K 100K 189K 12.89M 192K 1.29M 505K 6.42M 507K 496K 21.51M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
